Study of Individualized Amonafide to Treat Prostate Cancer
This study has been completed.
Sponsor:
Xanthus Pharmaceuticals, Inc.
Information provided by:
Xanthus Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00087854
First received: July 14, 2004
Last updated: April 21, 2008
Last verified: April 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2005 |
| Primary Completion Date: | December 2005 (Final data collection date for primary outcome measure) |